DN Decision Briefs / Evidence history

What changed?
Keep the record.

A publication trail for DN’s research. Dates identify our evidence reviews, not platform launches or independently observed operational events.

Browse Decision Briefs Explore Markets Research

What affects your saved research?

Save individual claims from all 14 platform briefs, then return here for explicitly linked DN publications. This is separate from your Markets shortlist and the publication checkpoint below. No account, live provider monitoring or alerts.

Only claim IDs, evidence versions, save dates and the updates available when you saved are stored in this browser. No private notes are collected, and saved claim IDs are not added to analytics events. Export to keep a copy; clearing browser data removes your saves. “Available when saved” does not mean read or verified.

Checking browser storage.

Import saved claims (JSON)

All published claim follow-ups

These records are available whether or not you save claims. They are separately dated additions, not replacements for the original snapshots.

Veranta detail pages retrieved; fee inconsistencies remain

2026-10-15 · affects 3 named claims

The collateral detail page is now accessible and describes USDC margin. This is documentation, not a deployed-collateral test.
The fee schedule and profit-sharing page are accessible. Maker/taker labels and Upside holding-cost descriptions conflict; no definitive all-in rate is established.
Documentation now describes session signers, expiry and revocation. Live approval and revocation behaviour remain untested.

Read follow-up

Open source-review data

gTrade collateral evidence revised

2026-10-22 · affects 1 named claims

The new snapshot distinguishes close-only DAI from collateral available for new positions. Your saved 1.0.0 snapshot remains unchanged.

Read follow-up

Open source-review data

Veranta evidence revised; fee conflicts remain unresolved

2026-10-22 · affects 4 named claims

The new snapshot incorporates the isolated-margin documentation. No deployed margin-control test is implied.
The review records an additional maker-rate unit discrepancy and retains the unresolved label and Upside borrowing conflicts. No definitive cost estimate is supplied.
Session expiry and revocation are now incorporated as documented controls; their live behaviour remains untested.
The current execution page contains Korean-equity confirmation placeholders. Provider performance examples remain unmeasured by DN.

Read follow-up

Open source-review data

Published evidence versions

Initial snapshots establish the baseline. When a new version is published, this page identifies changed evidence fields and links both versions. An unchanged review date alone does not prove that a provider’s terms remain current.

Platform or comparison

Publication type

Only versions added since my checkpoint

41 of 41 published versions shown.

Evidence revision